Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biovail Corporation
Biovail Announces Establishment of External Advisory Board
April 15th, 2009
Biovail Corporation (NYSE/TSX: BVF) announced the formation of an External Advisory Board (EAB) to oversee and provide medical, scientific, and commercial input into the Company’s development-pipeline efforts in specialty central nervous system disorders. Biovail’s EAB is comprised of Franklin M. Berger, Dr. Mark A. Cochran, Dr. Kathleen Clarence-Smith, Dr. Robert H. Lenox, Dr. Karoly Nikolich and Dr. Ian Ragan – exceptional individuals that bring a wealth of academic, business and product-development expertise and acumen to Biovail. “We are delighted to welcome these renowned individuals to Biovail’s External Advisory Board”, said Biovail’s Chief...
Source: Vaccine Weekly (2009-04-15)
|
